FibroGen
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch FibroGen and buy or sell other stocks, ETFs, and their options commission-free!About FGEN
Kyntra Bio, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It focuses on the hypoxia-inducible factor and connective tissue growth factor biology to develop medicines for the treatment of anemia, fibrotic disease, and cancer.
CEOThane Wettig, MBA
CEOThane Wettig, MBA
Employees34
Employees34
HeadquartersSan Francisco, California
HeadquartersSan Francisco, California
Founded1993
Founded1993
Employees34
Employees34
FGEN Key Statistics
Market cap30.43M
Market cap30.43M
Price-Earnings ratio0.23
Price-Earnings ratio0.23
Dividend yield—
Dividend yield—
Average volume31.24K
Average volume31.24K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$12.60
52 Week high$12.60
52 Week low$4.85
52 Week low$4.85
Stock Snapshot
FibroGen(FGEN) stock is priced at $7.52, giving the company a market capitalization of 30.43M. It carries a P/E multiple of 0.23.
On 2026-03-18, FibroGen(FGEN) shares started trading at —, with intraday highs of — and lows of —.
Trading activity shows a volume of 0, compared to an average daily volume of 31.24K.
The stock's 52-week range extends from a low of $4.85 to a high of $12.60.
The stock's 52-week range extends from a low of $4.85 to a high of $12.60.
People also own
Based on the portfolios of people who own FGEN. This list is generated using Robinhood data, and it’s not a recommendation.